ClinicalTrials.Veeva

Menu

Metabolism of Patients With Genetically Caused Cardiac Arrhythmia

University of Copenhagen logo

University of Copenhagen

Status

Unknown

Conditions

Long QT Syndrome

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Loss-of-function mutations in voltage-gated potassium channels cause long QT syndrome (LQTS) due to a prolonged cardiac repolarisation phase. Hypoteses: patients with loss-of-function mutations also exhibit altered hormone release upon glucose ingestion.

Full description

Loss-of-function mutations in voltage-gated potassium channels cause long QT syndrome (LQTS) due to a prolonged cardiac repolarisation phase.

Voltage-gated potassium (Kv-) channels are known for their relation to malignant cardiac arrhythmias, but also play a role in pancreatic alpha- and beta cell hormone secretion, and possibly in incretin hormone secretion. We hypothesised that patients with loss-of-function mutations also exhibit altered hormone release upon glucose ingestion.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

LQTS Gain of function Matched healthy controls

Exclusion criteria

none

Trial design

50 participants in 2 patient groups

Mutation
Description:
Patients with functional mutation in ion channels
Control
Description:
Matched control

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems